BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Rcadia Announces Initial U.S. COR Analyzer Beta Site Automated Coronary CTA Analysis Software Performs at St. James Healthcare Without Human Intervention


11/1/2007 8:55:03 AM

BOSTON, Nov. 1 /PRNewswire/ -- Rcadia Medical Imaging, Ltd., developer and marketer of innovative, patented computer-aided diagnostic software, announces the first installation of its COR Analyzer at St. James Healthcare in Butte, Montana.

Rcadia's COR Analyzer performs automatic segmentation and tracking of the coronary artery tree for Coronary CT angiogram (CTA) procedures without human intervention. The COR Analyzer system detects stenotic lesions in the major coronary arteries and automatically identifies patients without coronary artery disease with a very high negative predictive value. It uses proprietary image processing algorithms to produce a report that assists physicians accurately and quickly in evaluating patients with suspected coronary artery disease.

"The recent interest in using Coronary CTA in patients with acute chest pain has created a major need for interpreting these studies in a timely manner. Initial results with the Rcadia system at our center have been extremely positive. We are optimistic that the COR Analyzer will address many of the workflow issues in our practice," commented Anna Chacko, MD, Chief of Radiology at St. James Healthcare.

Rcadia's COR Analyzer is installed as a beta site at MNAP Diagnostics in Pennsylvania, with additional beta installations planned for November. "Beta sites will provide us with information to optimize and fine-tune the system to support physician workflow," noted Rcadia CEO, Shai Levanon. Levanon added, "We are currently setting up our distribution and technical support team in the U.S. and expect to initiate sales of the COR Analyzer system in the very near future."

CONTACT: Jeanne-Marie Phillips of HealthFlash Marketing for Rcadia Medical
Imaging, Ltd., +1-888-655-3434, jphillips@healthflashmarketing.com



Read at BioSpace.com

Rcadia
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES